ParaplegiaSymptoms, Doctors, Treatments, Advances & More
Paraplegia Overview
Learn About Paraplegia
Patterson Primary Care Clinic
Originally from the East Coast, Dr. Weigel spent more than 25 years in private practice in New Jersey. Dr. Weigel graduated from the medical school at Rutgers, the State University of New Jersey. He completed his residency at University of Medicine and Dentistry of New Jersey. Dr. Weigel is board certified in Internal Medicine. His clinical interests are chronic disease management and preventive care. He is passionate about spending time talking and listening to his patients.“My job is to make sure my patients make informed decisions about their healthcare. I want to catch disease processes early so they can be treated more efficiently.”When not working, Dr. Weigel can be found participating in outdoor activities such as skiing, snow shoeing and hiking with his wife and their two dogs. Dr. Weigel is rated as an Advanced provider by MediFind in the treatment of Paraplegia. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, Ureteroscopy, and Pacemaker Implantation. Dr. Weigel is board certified in American Board Of Internal Medicine.
Erasmus MC
Giovanni Stevanin practices practicing medicine in Rotterdam, Netherlands. Mr. Stevanin is rated as an Elite expert by MediFind in the treatment of Paraplegia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Paraplegia, Spasticity, and Acute Cerebellar Ataxia.
Rebecca Schule practices practicing medicine in Tuebingen, Germany. Ms. Schule is rated as an Elite expert by MediFind in the treatment of Paraplegia. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Spastic Paraplegia Type 7, Paraplegia, Spasticity, and Spastic Paraplegia Type 2.
Summary: The purpose of this research study is to measure the tolerability and preliminary efficacy of a drug, galantamine, to treat metabolic syndrome (MetS) by reducing circulating inflammation in people with spinal cord injury (SCI). Galantamine is FDA-approved for the treatment of Alzheimer's disease. Here, the drug is considered experimental for the purposes of this study.
Summary: Hereditary spastic paraplegia (HSP) is a rare neurological condition that causes stiffness, weakness, and difficulty walking due to damage in the nerves that control movement. This study will test whether a noninvasive form of spinal cord stimulation, called transcutaneous spinal cord stimulation (tSCS), can improve walking and reduce muscle stiffness in adults with HSP. In this study, participant...
